Microscopic Hematuria Flashcards

1
Q

What is the definition of microhematuria?

A

Guideline 1: 3 or more RBC/HPF on a single, properly collected urine specimen (Note: This has to be RBC seen on a microscopic exam- macroscopic blood does not count- see guideline 2 below)

Guideline 2: Clinicians should not define microhematuria by positive dipstick testing alone. A positive urine dipstick of trace blood or greater should prompt formal microscopic examination of the urine.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What should you pay particular attention to in the initial evaluation in a person with microhematuria?

A
Guideline 3: 
Perform a history and physical examination to assess risk factors for GU malignancy, medical renal disease, and non-malignant GU causes of microhemturia
-Age
-Gender
-Smoking
-LUTs
-Prior pelvic radiation
-Prior cyclophosphamide/ifosfamide chemo
-Exposure to dyes/chemicals
-Indwelling foley
-Family history of UC or lynch syndrome

Guideline 5: In persons with findings suggestive of a non-malignant or gynecology etiology, these persons should be evaluated with appropriate physical examination techniques and tests to identify the etiology. (IE: do a pelvic exam in women)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

How do you evaluate a person on anticoagulants or anti platelet drugs with microhematuria?

A

Guideline 4: They should have the same evaluation as someone not on these drugs.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

If a person is identified as having an UTI or a gynecology or non-malignant GU cause of having microhematuria, are you done with evaluation?

A

Guideline 6/7: You must obtain a urinalysis with microscopic examination to ensure resolution of the hematuria. If it persists or you can’t identify the etiology, you should perform a risk-based assessment of the microhematuria.

*** The panel acknowledges that there are some non-malignant causes such as BPH, nephrolithiasis, vaginal atrophy or prolapse, in which the MH won’t completely resolve even with appropriate management. In these cases you must use judgement and careful shared decision making to decide to pursue MH evaluation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

If a person is thought to have microhematuria secondary to medical renal disease are you done with evaluation?

A

Guideline 8: Refer these patients to nephrology. but still do a risk based urological evaluation.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

What are the low, intermediate and high risk categories of microhematuria?

A

Low risk (must meet all criteria): women age < 50, men age < 40, never smoker or < 10 pack years, 3-10 RBC/HPF on a single UA, no risk factors for GU malignancy

Intermediate risk (meet any one criteria): women age 50-59, men age 40-59, 10-30 pack years, 11-25 RBC/HPF on a single UA, repeat UA in a low risk patient with repeat 3-10 RBC/HPF, additional risk factors for UC.

High risk (meet any one criteria): Women or men >59 years, > 30 pack years, > 25 RBC/HPF, any gross hematuria

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

How should you treat a low risk person with microhematuria?

A

Guideline 10: Clinicians should engage in shared decision making to decide between repeating UA within 6 months or proceeding with cystoscopy and renal bladder ultrasound.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

How should you treat a low risk patient who has a repeat microhematuria who elected not to undergo initial evaluation?

A

Guideline 11: You should reclassify these patients as intermediate or high risk and perform cystoscopy with upper tract imaging

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

How should you work up an intermediate risk patient with microhematuria?

A

Guideline 12: Clinicians should perform cystoscopy and renal ultrasound

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

How should you work up a high risk hematuria patient?

A

Guideline 13: Cystoscopy and upper tract imaging:
1st preference is multiphasic CT urography (if GFR >30 and no iodine allergy)
2nd preference is MR urography
3rd preference is retrograde pyelography with non-contrast axial imaging or renal ultrasound

Special exception: pregnant women get RUS with axial imaging after delivery

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What type of cystoscopy should you perform in a person with microhematuria?

A

Guideline 14: Clinicians should perform white light cystoscopy as part of the workup (blue light costs more money, time and has not been studied in this setting and may lead to unnecessary biopsies- it is NOT currently recommended)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What may you do in someone with persistent microhematuria previously worked up by renal ultrasound?

A

Guideline 15: Perform additional imaging of the upper urinary tract

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What should you do in a intermediate risk patient with a family history of RCC or a known genetic renal tumor syndrome?

A

Guideline 16: You should get upper tract imaging

(known genetic renal tumor syndromes are: VHL, BHD, hereditary papillary RCC, hereditary leiomyomatosis RCC, and tuberous sclerosis)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

What is the role of urinary markers in the workup of microhematuria?

A

Guidelien 17: Do not use urine cytology or makers in the initial evaluation of microhematuria

Guideline 18: You may obtain urine cytology for patients with persistent microhematuria after a negative work up who have irritative voiding symptoms or risk factors for CIS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

After a negative microhematuria workup, how often should you repeat a urinalysis?

A

Guideline 19: Within 12 months

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

After a negative microhematuria evaluation and negative subsequent urinalysis, what should you do?

A

Guideline 20: the UA should be repeated in 12 months after an initial negative evaluation. However, if the subsequent UA is negative, you can stop any further workup

17
Q

For persons with a prior negative microhematuria workup and persistent microhematuria, what is recommended?

A

Guideline 21: Shared decision making regarding need for additional workup

18
Q

For persons with a prior negative microhematuria workup and worsening microhematuria or gross hematuria or new symptoms, what is recommended?

A

Guideline 22: It is recommended that you have further workup though what this workup entails is not specified and it ultimately says this should be shared decision making based on patient preferences and physician judgement…..